For the interest and benefit of ESCP members, the Research Committee are going to write a monthly short report on a significant colorectal article that has been published in the last six months.
These summaries should provide an informative read on significant developments that have the potential to help patients. We would welcome your suggestions regarding articles and also your ideas on how this initiative may be developed.
On 31 Mar 2022
March's paper of the month looks at the comparison between immunochemical testing for fecal blood (FIT) and Flexible Sigmoidoscopy (FS) as tools for colorectal cancer screening in a Norwegian population.On 2 Mar 2022
February's paper of the month looks at the Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancerOn 9 Sep 2021
August’s paper of the month looks at the PRODIGE-7 trial, a multicentre randomised open-label, phase 3 trial which sought to determine whether hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreductive surgery for colorectal peritoneal metastasesOn 1 Jul 2021
July's Paper of the Month looks at how obesity shapes metabolism in the tumour microenvironment to suppress anti-tumour immunity.On 10 Jun 2021
June’s paper of the month looks at the PRODIGE-23 trial, a randomised phase 3 clinical trial which sought to determine whether total neoadjuvant chemotherapy (TNT) before surgery improved disease-free survival (DFS) compared with standard preoperative chemoradiotherapy (CRT) in patients with locally advanced rectal cancer.ESCP Secretariat
c/o MCI UK Ltd
Unit 24/22 South
Building 4000, Langstone Park
Langstone Road
Havant PO9 1SA
01730 715 208
